NCT03452488: A trial that was reported late by Biophytis
This trial has reported, although it was 995 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03452488 |
|---|---|
| Title | Safety and Efficacy of BIO-101 175 mg b.i.d. and 350 mg b.i.d. 26-week Oral Administration to Patients Suffering From Age-related SARcopenia, Including Sarcopenic Obesity, Aged ≥65 Years and at Risk of Mobility Disability |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 7, 2017 |
| Completion date | April 26, 2020 |
| Required reporting date | April 26, 2021, midnight |
| Actual reporting date | Jan. 16, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 995 |